SUMMARY An evaluation of C reactive protein as an indicator of the progress of acute pancreatitis has been made, and the data have been compared with the information given by the white cell count, erythrocyte sedimentation rate, and temperature and by two antiproteases-a, protease inhibitor and a, antichymotrypsin. The main value of C reactive protein is .to provide a guide to the severity of the inflammation and to increase clinicians' awareness of the patient's enhanced risk of developing pancreatic collections when the C reactive protein concentration remains high (>100 mg/l) at the end of the first week of the illness. In this respect C reactive protein concentrations are superior to white cell count, erythrocyte sedimentation rate, and temperature and the concentrations of antiproteases.
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An increased serum C reactive protein concentration is well recognised as a non-specific response to a wide variety of tissue injuries. ' 2 Sequential measurements of C reactive protein concentration can be helpful in providing a warning of inflammatory complications in disease-for example, postoperative sepsis and thrombosis-and its response to treatment.3 4 But in complex inflammatory diseases there is no a priori way of forecasting whether C reactive protein is going to provide useful information in clinical decision making.
Nevertheless, the rapid respohse of C reactive protein to changes in the intensity of the inflammatory stimulus suggest that it might be valuable in the assessment and monitoring of acute pancreatitis.
The clinical problem of particular interest was to test whether C reactive protein measurements could reflect the severity of the attack and thereby provide a warning of the likely development of pancreatic collections (pseudocyst, abscess, and necrosis), which can arise insidiously and be life threatening. 5 6 Most pancreatic collections probably arise when part of the duct system is affected in an area of necrosis which forms early in the attack of acute pancreatitis. Although a collection of fluid or a sequestrum may subsequently develop over the course of days or weeks, it is probable that Accepted for publication 14 November 1983. inflammation around the necrotic focus exists throughout the period of evolution. For this reason we thought it might be possible to screen for "foccult' collections using plasma indicators of the inflammatory response.
We have studied the intensity of the C reactive protein response and its rate of change in cases of acute pancreatitis of varying severity. The value of this test was compared with the information provided by the concentration of a, antichymotrypsin and a, protease inhibitor. The white cell count and erythrocyte sedimentation rate, standard indices of inflammation, were used as reference data.
The design precluded using the new data for clinical decision making; however, the results indicate that C reactive protein can identify severe pancreatitis which may not be obvious at its onset, and lay the basis for prospective trials.
Patients and methods
Fifty-five patients with acute pancreatitis were studied. The diagnosis was based on a plasma amylase value in excess of 1200 IU/ 1 combined with consistent clinical features in 48 patients and on the findings at laparotomy in seven patients.
The patients were treated conventionally, which in 30 patients included a diagnostic peritoneal lavage. They were discharged from hospital when the attack was thought to have settled according to routine clinical criteria. Investigations such as ultrasound examination and computed tomography were carried out only when there was clinical suspicion of a pancreatic collection. After discharge from hospital all patients were followed up for six months. The first 49 patients were consecutive, but in order to provide sufficient numbers for analysis data from a further six patients who had developed a pancreatic collection were added to the series. Each attack was classified as mild or severe according to clinical criteria. A severe attack was defined as one which resulted in more than 14 days in hospital, one which gave rise to a complication such as a pseudocyst or abscess, or one which was fatal. According to these criteria, there were 39 mild and 16 severe attacks (Table 1) . Pancreatic collections developed in 11 patients (eight pseudocysts and three abscesses), six of whom were treated by operation.
Two patients in this study were discharged without recognition of their collection, only to be readmitted six and 10 days later. Pancreatic collections were diagnosed 4 to 29 days after admission to hospital with pancreatitis and confirmed by computed tomography in six patients, ultrasound in four, and at laparotomy in one.
During the initial 13 days in hospital, plasma samples were collected on roughly alternate days and stored at -20°C. C reactive protein, a,-protease inhibitor, and antichymotrypsin were measured by radial immunodiffusion,8 using antisera and standards obtained from Behringwerke AG, Marburg/Lahn, FRG, and Seward Immunostics, 
Results
The criteria which are currently used to make an early prediction of the severity of acute pancreatitis failed to recognise several of the severe attacks in this study. This was because of their failure to predict severe pancreatitis (as defined) unless the patient developed evidence of the early shock like component of the illness. Only eight of the 16 severe attacks exhibited this shock like pattern.
Of the severe attacks 36% were correctly recognised by peritoneal lavage, and the multiple criteria Table 2) . Body temperature, erythrocyte sedimentation rate, and a, protease inhibitor concentrations failed to discriminate between severe and mild attacks. Although high values were often found in severe attacks, there was overlap of the 95% confidence limits of the means of the mild and severe groups throughout the study. Better discrimination was provided by white blood cell count, antichymotrypsin and C reactive protein concentrations (Fig. 1, 2, 3) . A difference in the white blood cell count between the severe and mild attacks was apparent on the day of admission to hospital, but the initial concentration of C reactive protein and antichymotrypsin could not differentiate the two groups. As the acute phase response became established, higher concentrations of C reactive protein and antichymotrypsin were sustained in severe attacks, reaching their maximum values towards the end of the first week and then falling. C reactive protein appeared to provide considerably better discrimination between mild and severe pancreatitis than the white blood cell count or antichymotrypsin concentration. The fall of C reactive protein towards normal in severe cases was consistently delayed. Individual C reactive protein data are shown in Fig.  4 . The overlap of C reactive protein concentrations between the two groups was relatively small.
In analysing these results severe attacks have been considered as a single group. Fig. 5 shows mean C reactive protein concentrations in severe attacks subdivided into two groups according to the development of a pancreatic collection. The rise and fall of C reactive protein concentration in these two groups was similar, indicating that the concentrations of C reactive protein did not appear to differentiate the attacks which were severe because a collection developed from those that were severe for other reasons. 
Discussion
Of the indices of inflammation studied, C reactive protein differentiated mild and severe attacks with greatest precision. Differentiation became clearer after the first week, and the overlap in the data during the initial phase of the disease is consistent with other findings." a,-protease inhibitor, another acute phase reactant protein, usually rises more slowly and reaches its peak later, the time course of antichymotrypsin being intermediate. Both these types of reponse were reflected in the results of this study. C reactive protein rose to higher concentrations in patients with severe disease, as has been shown previously, '5 but it was the rate of fall from peak concentrations which provided greater differentiation between grades of severity.
There 
